DBV Technologies | Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Alnylam Pharmaceuticals USD 233.89M 16.7M 2025-09
Amarin USD 458.89M 6.03M 2025-09
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
DBV Technologies USD 52.85M 33.37M 2025-09
Esperion Therapeutics USD -451.36M 17.85M 2025-09
Galectin Therapeutics USD -83.87M 11.06M 2024-06
Halozyme Therapeutics USD 503.92M 171.17M 2025-09
Incyte USD 5.17B 516.28M 2025-12
Insmed USD 945.57M 304.16M 2025-09
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
PTC Therapeutics USD -155.76M 50.79M 2025-09
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
United Therapeutics USD 6.59B 583.4M 2025-09


DBV Technologies Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.